The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System

Sean P. David, Lavisha Singh, Jaclyn Pruitt, Andrew Hensing, Peter J. Hulick, David O. Meltzer, Peter H. O’Donnell, H. Mark Dunnenberger
doi: https://doi.org/10.1101/2021.10.22.21265071

Article Information

doi 
https://doi.org/10.1101/2021.10.22.21265071
History 
  • October 25, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Sean P. David1,2,*,
  2. Lavisha Singh1,
  3. Jaclyn Pruitt1,
  4. Andrew Hensing1,
  5. Peter J. Hulick1,2,
  6. David O. Meltzer2,
  7. Peter H. O’Donnell2 and
  8. H. Mark Dunnenberger1
  1. 1NorthShore University HealthSystem, Evanston, IL
  2. 2University of Chicago Pritzker School of Medicine, Chicago, IL
  1. ↵*Corresponding author; email: spdavidmd{at}gmail.com
Back to top
Posted October 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email
The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System
Sean P. David, Lavisha Singh, Jaclyn Pruitt, Andrew Hensing, Peter J. Hulick, David O. Meltzer, Peter H. O’Donnell, H. Mark Dunnenberger
medRxiv 2021.10.22.21265071; doi: https://doi.org/10.1101/2021.10.22.21265071
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area